1. Electroporation-Based Treatments in Small Animal Veterinary Oral and Maxillofacial Oncology
- Author
-
Maja Čemažar, Gregor Sersa, Natasa Tozon, Ana Nemec, Nina Milevoj, and Ursa Lampreht Tratar
- Subjects
electroporation ,Oncology ,dogs ,medicine.medical_specialty ,Electrochemotherapy ,040301 veterinary sciences ,medicine.medical_treatment ,Gene electrotransfer ,Review ,Veterinary oncology ,0403 veterinary science ,03 medical and health sciences ,oral tumors ,Small animal ,Internal medicine ,medicine ,elektrokemoterapija ,Clinical efficacy ,genski elektroprenos ,030304 developmental biology ,0303 health sciences ,lcsh:Veterinary medicine ,General Veterinary ,business.industry ,Melanoma ,Electroporation ,cats ,04 agricultural and veterinary sciences ,medicine.disease ,Radiation therapy ,udc:636.09:616 ,ustni tumorji ,mačke ,dog ,gene electrotransfer ,psi ,lcsh:SF600-1100 ,Veterinary Science ,Elektroporacija ,electrochemotherapy (ECT) ,business - Abstract
Electroporation is a method of inducing an increase in permeability of the cell membrane through the application of an electric field and can be used as a delivery method for introducing molecules of interest (e.g., chemotherapeutics or plasmid DNA) into cells. Electroporation-based treatments (i.e., electrochemotherapy, gene electrotransfer, and their combinations) have been shown to be safe and effective in veterinary oncology, but they are currently mostly recommended for the treatment of those solid tumors for which clients have declined surgery and/or radiotherapy. Published data show that electroporation-based treatments are also safe, simple, fast and cost-effective treatment alternatives for selected oral and maxillofacial tumors, especially small squamous cell carcinoma and malignant melanoma tumors not involving the bone in dogs. In these patients, a good local response to treatment is expected to result in increased survival time with good quality of life. Despite emerging evidence of the clinical efficacy of electroporation-based treatments for oral and maxillofacial tumors, further investigation is needed to optimize treatment protocols, improve clinical data reporting and better understand the mechanisms of patients' response to the treatment.
- Published
- 2020
- Full Text
- View/download PDF